Abstract
The persistence of central memory CD4+ T cells (TCM cells) is a major correlate of immunological protection in HIV/AIDS, as the rate of TCM cell decline predicts HIV disease progression. In this study, we show that TCM cells and effector memory CD4+ T cells (TEM cells) from HIV+ elite controller (EC) subjects are less susceptible to Fas-mediated apoptosis and persist longer after multiple rounds of T cell receptor triggering when compared to TCM and TEM cells from aviremic successfully treated (ST) subjects or from HIV− donors. We show that persistence of TCM cells from EC subjects is a direct consequence of inactivation of the FOXO3a pathway. Silencing the transcriptionally active form of FOXO3a by small interfering RNA or by introducing a FOXO3a dominant-negative form (FOXO3a Nt) extended the long-term survival of TCM cells from ST subjects to a length of time similar to that of TCM cells from EC subjects. The crucial role of FOXO3a in the survival of memory cells will help shed light on the underlying immunological mechanisms that control viral replication in EC subjects.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kaech, S.M., Wherry, E.J. & Ahmed, R. Effector and memory T cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2, 251–262 (2002).
Sallusto, F., Geginat, J. & Lanzavecchia, A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22, 745–763 (2004).
Zanetti, M. & Franchini, G. T cell memory and protective immunity by vaccination: is more better? Trends Immunol. 27, 511–517 (2006).
Bostik, P. et al. Central memory CD4 T cells are the predominant cell subset resistant to anergy in SIV disease resistant sooty mangabeys. AIDS 20, 181–188 (2006).
Day, C.L. et al. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J. Clin. Invest. 112, 831–842 (2003).
Letvin, N.L. et al. Preserved CD4· central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 312, 1530–1533 (2006).
Okoye, A. et al. Progressive CD4· central memory T cell decline results in CD4. effector memory insufficiency and overt disease in chronic SIV infection. J. Exp. Med. 204, 2171–2185 (2007).
Cao, Y., Qin, L., Zhang, L., Safrit, J. & Ho, D.D. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332, 201–208 (1995).
Harrer, T. et al. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J. Immunol. 156, 2616–2623 (1996).
Birkenkamp, K.U. & Coffer, P.J. Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem. Soc. Trans. 31, 292–297 (2003).
Lin, L., Hron, J.D. & Peng, S.L. Regulation of NF-κB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21, 203–213 (2004).
Urbich, C. et al. FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB J. 19, 974–976 (2005).
Riou, C. et al. Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4· central memory T cells. J. Exp. Med. 204, 79–91 (2007).
Kops, G.J. et al. Control of cell cycle exit and entry by protein kinase B–regulated forkhead transcription factors. Mol. Cell. Biol. 22, 2025–2036 (2002).
Lavoie, P.M., Dumont, A.R., McGrath, H., Kernaleguen, A.E. & Sekaly, R.P. Delayed expansion of a restricted T cell repertoire by low-density TCR ligands. Int. Immunol. 17, 931–941 (2005).
Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857–868 (1999).
Hu, M.C. et al. IκB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117, 225–237 (2004).
Harari, A. et al. Analysis of HIV-1– and CMV-specific memory CD4 T cell responses during primary and chronic infection. Blood 100, 1381–1387 (2002).
Picker, L.J. et al. Insufficient production and tissue delivery of CD4· memory T cells in rapidly progressive simian immunodeficiency virus infection. J. Exp. Med. 200, 1299–1314 (2004).
Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263–267 (1996).
Charvet, C. et al. Proteolytic regulation of Forkhead transcription factor FOXO3a by caspase-3–like proteases. Oncogene 22, 4557–4568 (2003).
Brunet, A. et al. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol. Cell. Biol. 21, 952–965 (2001).
Biancotto, A. et al. Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1. Blood 109, 4272–4279 (2007).
Knight, S.C., Macatonia, S.E. & Patterson, S. HIV I infection of dendritic cells. Int. Rev. Immunol. 6, 163–175 (1990).
Wilson, J.D. et al. Loss of CD4· T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease. J. Infect. Dis. 182, 792–798 (2000).
Sun, Y. et al. Dysfunction of simian immunodeficiency virus/simian human immunodeficiency virus–induced IL-2 expression by central memory CD4· T lymphocytes. J. Immunol. 174, 4753–4760 (2005).
Kim, J.R. et al. Polymorphisms in FOXO gene family and association analysis with BMI. Obesity (Silver Spring) 14, 188–193 (2006).
Philp, A.J. et al. The phosphatidylinositol 3′-kinase p85α gene is an oncogene in human ovarian and colon tumors. Cancer Res. 61, 7426–7429 (2001).
Shamim, Z. et al. Genetic polymorphisms in the genes encoding human interleukin-7 receptor-α: prognostic significance in allogeneic stem cell transplantation. Bone Marrow Transplant. 37, 485–491 (2006).
Wu, H.C. et al. IL-2 gene C/T polymorphism is associated with prostate cancer. J. Clin. Lab. Anal. 20, 245–249 (2006).
Hendel, H. et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J. Immunol. 162, 6942–6946 (1999).
Samson, M. et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722–725 (1996).
Acknowledgements
We thank D. Trono (University of Geneva) for the lentiviral vector pWPI, packaging plasmid psPAX2 and envelope plasmid pMD2G. We thank M. Lainesse and Y. Chouikh for expert technical assistance. We thank L. Greller and R. Somogyi for statistical assistance. We also want to thank all study participants. J.v.G. is a recipient of the Fond de la Recherche Médicale fellowship, L.T. and E.A.S. are funded by the Canadian Institutes of Health Research and N.C. is supported by The American Foundation for AIDS Research (fellowship number 106634-38-RFRL). This study was supported by funds from the National Institutes of Health, the Canadian Institutes of Health Research, Genome Quebec, Genome Canada, Fonds de Recherche en Santé du Quebec and the Canadian Network for Vaccines and Immunotherapeutics. R.-P.S. is the Canada Research Chair in Human Immunology. J.-P.R., is a clinician-scientist supported by Fonds de Recherche en Santé du Quebec. We thank R. Seder, M. Lederman, Q. Eichbaum and P. Ancuta for critically reviewing the manuscript. We would also like to thank the members of the Cleveland Immunopathogenesis Consortium for helpful discussions.
Author information
Authors and Affiliations
Contributions
J.v.G. performed most of the experiments and wrote the article. R.-P.S. and E.K.H. generated the concept, supervised the experiments and wrote the article. F.A.P., Z.H., Y.Z. and Y.S. worked on the siRNA and lentiviral construct; N.C. did the p24 ELISA; B.Y.-D., E.A.S., L.T., M.E.F. and C.R. worked on the in vitro system; S.G. performed sorting; G.B. and P.W. worked on the statistics; and J.-P.R. and R.S.B. recruited subjects and helped with the discussion.
Corresponding authors
Supplementary information
Supplementary Text and Figures
Supplementary Figs. 1 and 2 (PDF 2634 kb)
Rights and permissions
About this article
Cite this article
van Grevenynghe, J., Procopio, F., He, Z. et al. Transcription factor FOXO3a controls the persistence of memory CD4+ T cells during HIV infection. Nat Med 14, 266–274 (2008). https://doi.org/10.1038/nm1728
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1728
This article is cited by
-
Virus-induced FoxO factor facilitates replication of human cytomegalovirus
Archives of Virology (2022)
-
FOXO1 promotes HIV latency by suppressing ER stress in T cells
Nature Microbiology (2020)
-
Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency
Retrovirology (2019)
-
Metabolic exhaustion in infection, cancer and autoimmunity
Nature Immunology (2018)
-
A transcriptome-based model of central memory CD4 T cell death in HIV infection
BMC Genomics (2016)